KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Short term Debt (2016 - 2020)

Neogenomics' Short term Debt history spans 11 years, with the latest figure at $5.0 million for Q1 2020.

  • For Q1 2020, Short term Debt fell 36.49% year-over-year to $5.0 million; the TTM value through Mar 2020 reached $5.0 million, down 36.49%, while the annual FY2019 figure was $5.0 million, 36.49% down from the prior year.
  • Short term Debt reached $5.0 million in Q1 2020 per NEO's latest filing, roughly flat from $5.0 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $7.9 million in Q4 2018 to a low of $596000.0 in Q1 2016.
  • Average Short term Debt over 5 years is $4.5 million, with a median of $4.2 million recorded in 2018.
  • Peak YoY movement for Short term Debt: tumbled 57.72% in 2016, then surged 543.79% in 2017.
  • A 5-year view of Short term Debt shows it stood at $3.8 million in 2016, then changed by 0.0% to $3.8 million in 2017, then surged by 109.95% to $7.9 million in 2018, then plummeted by 36.49% to $5.0 million in 2019, then changed by 0.0% to $5.0 million in 2020.
  • Per Business Quant, the three most recent readings for NEO's Short term Debt are $5.0 million (Q1 2020), $5.0 million (Q4 2019), and $6.2 million (Q3 2019).